Video

CTTI Survey Identifies Why Many PIs Drop Out After One Trial

Source: Clinical Leader

Morgan Hanger of CTTI discusses their survey of 201 PIs in FDA-regulated drug trials that indicated over half (108) participated only once in a trial, citing time constraints, workload, safety reporting, and financial burdens were why they did not continue. Despite these challenges, 44% wanted to continue but lacked opportunities, suggesting a disconnect in trial recruitment. 

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)